INSMED INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
INSMED INC (INSM) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$417.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-03
- INSMED INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$417.00K.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$772.00K.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$1.30M.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$1.54M.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$4.20M.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$3.45M.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$5.34M, a 501.88% decline from fiscal 2013.
- INSMED INC net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $1.33M, a 97.84% decline from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$417.00K 10-Q · filed 2017-05-03 | -$1.19M derived: sum of 2 quarters · filed 2017-05-03 | -$2.49M derived: sum of 3 quarters · filed 2017-05-03 | -$4.03M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-12-31 | -$772.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$2.07M derived: sum of 2 quarters · filed 2017-02-23 | -$3.61M derived: sum of 3 quarters · filed 2017-02-23 | -$4.20M 10-K · filed 2017-02-23 |
| 2016-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$2.84M derived: sum of 2 quarters · filed 2016-11-03 | -$3.43M 10-Q · filed 2016-11-03 | -$3.83M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$2.13M 10-Q · filed 2016-08-04 | -$2.54M derived: sum of 3 quarters · filed 2017-05-03 | -$3.39M derived: sum of 4 quarters · filed 2017-05-03 |
| 2016-03-31 | -$588.00K 10-Q · filed 2017-05-03 | -$995.00K derived: sum of 2 quarters · filed 2017-05-03 | -$1.85M derived: sum of 3 quarters · filed 2017-05-03 | -$2.78M derived: sum of 4 quarters · filed 2017-05-03 |
| 2015-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$1.26M derived: sum of 2 quarters · filed 2017-02-23 | -$2.19M derived: sum of 3 quarters · filed 2017-02-23 | -$3.45M 10-K · filed 2017-02-23 |
| 2015-09-30 | -$853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.78M derived: sum of 2 quarters · filed 2016-11-03 | -$3.05M 10-Q · filed 2016-11-03 | -$4.57M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$2.19M 10-Q · filed 2016-08-04 | -$3.72M derived: sum of 3 quarters · filed 2017-02-23 | -$6.64M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$1.26M 10-Q · filed 2016-05-05 | -$2.79M derived: sum of 2 quarters · filed 2017-02-23 | -$5.71M derived: sum of 3 quarters · filed 2017-02-23 | -$6.27M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.45M derived: sum of 2 quarters · filed 2017-02-23 | -$5.01M derived: sum of 3 quarters · filed 2017-02-23 | -$5.34M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$3.48M derived: sum of 2 quarters · filed 2015-11-06 | -$3.81M 10-Q · filed 2015-11-06 | -$3.93M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$895.00K 10-Q · filed 2015-08-06 | -$1.01M derived: sum of 3 quarters · filed 2016-02-25 | $925.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$331.00K 10-Q · filed 2015-05-07 | -$444.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.49M derived: sum of 3 quarters · filed 2016-02-25 | $1.16M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.82M derived: sum of 2 quarters · filed 2016-02-25 | $1.49M derived: sum of 3 quarters · filed 2016-02-25 | $1.33M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.60M derived: sum of 2 quarters · filed 2014-11-06 | $1.44M 10-Q · filed 2014-11-06 | $46.03M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | -$491.00K 10-Q · filed 2014-08-06 | $44.10M derived: sum of 3 quarters · filed 2015-02-27 | $44.07M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$161.00K 10-Q · filed 2014-05-08 | $44.43M derived: sum of 2 quarters · filed 2015-02-27 | $44.40M derived: sum of 3 quarters · filed 2015-02-27 | $48.52M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $44.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $44.56M derived: sum of 2 quarters · filed 2015-02-27 | $48.68M derived: sum of 3 quarters · filed 2015-02-27 | $61.52M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $4.09M derived: sum of 2 quarters · filed 2013-11-05 | $16.93M 10-Q · filed 2013-11-05 | |
| 2012-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $16.96M 10-Q · filed 2013-08-06 | ||
| 2012-03-31 | $12.84M 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | $34.36M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |